These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3164472)

  • 21. VM-26 as a second drug in the treatment of brain gliomas.
    Kessinger A; Lemon HM; Foley JF
    Cancer Treat Rep; 1979 Mar; 63(3):511-2. PubMed ID: 427830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances on ACNU in the past 10 years].
    Niitani H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):727-31. PubMed ID: 3281592
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of malignant brain tumours with ACNU and phenobarbital: continuous infusion of ACNU into internal carotid artery and systemic administration of phenobarbital.
    Yumitori K; Handa H; Teraura T; Yamashita J
    Acta Neurochir (Wien); 1984; 70(3-4):155-68. PubMed ID: 6585127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors.
    Hori T; Muraoka K; Saito Y; Sasahara K; Inagaki H; Inoue Y; Adachi S; Anno Y
    J Neurosurg; 1987 Mar; 66(3):372-8. PubMed ID: 3469331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Two cases of central nervous system leukemia which responded excellently to intra-arterial injection of ACNU].
    Ohyasiki K; Ohsumi A; Ito H; Umehara S; Ohyashiki J; Yunokawa K; Osamura S; Tomita T; Ohta Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):942-7. PubMed ID: 6964042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCNU treatment for recurrent malignant gliomas.
    Levin VA; Resser KJ; McGrath L; Vestnys P; Nutik S; Wilson CB
    Cancer Treat Rep; 1984; 68(7-8):969-73. PubMed ID: 6744348
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma (author's transl)].
    Mineura K; Mori T; Katakura R; Sasaki T
    No Shinkei Geka; 1981; 9(3):257-65. PubMed ID: 6941099
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of brain tumors with 1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Takeuchi J; Nakao S; Handa H
    Nihon Geka Hokan; 1973 Apr; 42(2):184-9. PubMed ID: 4738478
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study on postoperative local chemotherapy of malignant brain tumors using ACNU and PSK].
    Saito Y; Hori T; Takami M; Muraoka K; Hokama Y; Numata H
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1963-71. PubMed ID: 6577813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
    Papavero L; Loew F; Jaksche H
    Acta Neurochir (Wien); 1987; 85(3-4):128-37. PubMed ID: 3035882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of tumors of the central nervous system].
    Hildebrand J
    Rev Med Brux; 1987 Apr; 8(4):195-8. PubMed ID: 3589267
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
    Yoshida J; Shibuya N; Kobayashi T; Kageyama N
    Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of phenobarbital on the metabolism of ACNU in vivo].
    Nagashima T; Matsutani M; Kohono T
    No To Shinkei; 1983 Jul; 35(7):677-82. PubMed ID: 6578801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
    Suda K; Nakasu S; Saito A
    Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
    [No Abstract]   [Full Text] [Related]  

  • 36. [Malignant gliomas: current status and therapeutic prospectives].
    Adinolfi D; Butti G; Spanu G; Silvani V; Messina A; Knerich R
    G Ital Chemioter; 1985; 32(1):93-8. PubMed ID: 3830798
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy of experimental brain tumors: preliminary studies.
    Schwartz J; Kott E; Elizan TS
    Mt Sinai J Med; 1974; 41(1):205-10. PubMed ID: 4361051
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemotherapy with ACNU and radiation therapy in malignant glioma in cerebral hemisphere of adult].
    Miyagami M; Tsubokawa T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1447-53. PubMed ID: 2117885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACNU-resistant mutants of 9L rat glioma cell line. Isolation and preliminary characterization of these subclones.
    Kokunai T; Tamaki N; Matsumoto S
    J Neurosurg; 1985 Oct; 63(4):583-8. PubMed ID: 3861792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fotemustine in the treatment of brain primary tumors and metastases.
    Khayat D; Giroux B; Berille J; Cour V; Gerard B; Sarkany M; Bertrand P; Bizzari JP
    Cancer Invest; 1994; 12(4):414-20. PubMed ID: 8032964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.